The page is the record's research on the issuer — no analyst, no rating, no view. # ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing ARS Pharmaceuticals, Inc. is listed on NASDAQ under ticker SPRY. ISIN US82835W1080; LEI not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). Security type Corporate; segment not on the record; sector 2834 Pharmaceutical Preparations; jurisdiction United States, Delaware. Status: listed, not halted. ## The disclosure read The record holds 77 filings in the window 2025-11-08 to 2026-11-08, on 41 filing days, by type: 28 directors' dealings, 33 regulatory filings, 10 results, 3 AGM/EGM, and 3 director changes. Median gap between filing days is 5.5 days. Latest filing is a results filing dated 2026-11-05, 3 days before the record date. NASDAQ peers: 4,359 issuers, median cadence gap 6.0 days, median 52 filings, median latency 5.0 days. Sector peers: 526 issuers, median cadence gap 6.0 days, median 63.0 filings, median latency 4.0 days. ## Auditor The auditor is not on the record (no dei:AuditorName tag on the latest annual report cover; foreign private issuers and older filings carry none). Location not on the record. No auditor changes are on the record. ## Events and halts The record holds no listing, delisting or name change lines. Domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). Segment move is not on the record (exchange tier transfers are not EDGAR filings). Halt flag: listed, not halted. ## Orderability The outcome is not determinable: the chapter's orderability section carries no client categories, so the outcome cannot name its client category. Rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1; chapter as of 2026-11-04. ## Coverage None found: the issuer's investor-relations page names no research houses on the pages read. The count is 0. ## Open research None found: no openly published research notes are on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001671858.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/SPRY (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/SPRY (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/SPRY · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp